ProciseDx gets CE Mark for Infliximab and Adalimumab point of care testing

The ProciseDx instrument provides diagnostics results in 2 minutes from a finger prick drop of blood. (Credit: ProciseDx.)



Related Article
Recommended Whitepaper

View More